Dr. Reddy Laboratories - 1QFY2014 Result Preview - Angel Broking

DRL is expected to post a top-line growth of 31.4% to Rs. 3,340cr, due to impact of a higher base of the corresponding period of the previous year. The company is expected to see strong traction in its Indian and Russian formulation businesses as well. The company is expected to post an OPM of 21.1%, down from 21.9% in 1QFY2013. The company is expected to post a net profit of Rs. 453cr, a growth of 34.8% yoy.

We maintain our accumulate on the stock.

Source : Equity Bulls

Keywords